Anatara Cash And Short Term Investments vs Total Current Liabilities Analysis

ANR Stock   0.06  0  1.72%   
Anatara Lifesciences financial indicator trend analysis is way more than just evaluating Anatara Lifesciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anatara Lifesciences is a good investment. Please check the relationship between Anatara Lifesciences Cash And Short Term Investments and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cash And Short Term Investments vs Total Current Liabilities

Cash And Short Term Investments vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anatara Lifesciences Cash And Short Term Investments account and Total Current Liabilities. At this time, the significance of the direction appears to have very week relationship.
The correlation between Anatara Lifesciences' Cash And Short Term Investments and Total Current Liabilities is 0.25. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Anatara Lifesciences, assuming nothing else is changed. The correlation between historical values of Anatara Lifesciences' Cash And Short Term Investments and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Anatara Lifesciences are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash And Short Term Investments i.e., Anatara Lifesciences' Cash And Short Term Investments and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.25
Relationship DirectionPositive 
Relationship StrengthVery Weak

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Anatara Lifesciences balance sheet. This account contains Anatara Lifesciences investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Anatara Lifesciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Current Liabilities

Total Current Liabilities is an item on Anatara Lifesciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Anatara Lifesciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Anatara Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anatara Lifesciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 1.6 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.8 M in 2024.
 2021 2022 2023 2024 (projected)
Cost Of Revenue24.7K24.8K748.9K786.4K
Research Development747.2K1.6M748.9K781.0K

Anatara Lifesciences fundamental ratios Correlations

0.330.80.230.360.330.25-0.520.311.00.66-0.810.250.430.99-0.160.261.00.70.920.29-0.130.150.18-0.180.52
0.330.060.540.860.68-0.1-0.560.790.30.51-0.08-0.520.210.250.37-0.260.33-0.040.330.73-0.320.030.08-0.08-0.09
0.80.060.2-0.030.230.47-0.430.040.820.55-1.00.250.410.82-0.170.040.80.570.620.14-0.260.180.16-0.170.19
0.230.540.20.40.74-0.27-0.570.690.220.49-0.22-0.61-0.060.130.49-0.260.23-0.260.280.77-0.890.130.16-0.15-0.51
0.360.86-0.030.40.490.02-0.420.760.310.430.01-0.330.080.250.21-0.080.35-0.170.340.55-0.050.180.25-0.250.12
0.330.680.230.740.49-0.14-0.890.60.320.79-0.26-0.810.520.250.71-0.430.33-0.020.290.94-0.650.090.11-0.1-0.46
0.25-0.10.47-0.270.02-0.14-0.16-0.110.250.25-0.470.290.280.28-0.250.190.250.27-0.13-0.330.320.020.02-0.020.23
-0.52-0.56-0.43-0.57-0.42-0.89-0.16-0.51-0.51-0.970.460.59-0.6-0.46-0.540.29-0.51-0.25-0.37-0.710.51-0.07-0.090.080.29
0.310.790.040.690.760.6-0.11-0.510.270.47-0.06-0.4-0.160.210.15-0.210.31-0.170.330.63-0.420.080.14-0.14-0.13
1.00.30.820.220.310.320.25-0.510.270.66-0.820.260.440.99-0.160.271.00.730.920.27-0.130.140.17-0.170.51
0.660.510.550.490.430.790.25-0.970.470.66-0.58-0.430.60.620.43-0.170.660.380.490.6-0.410.070.09-0.09-0.12
-0.81-0.08-1.0-0.220.01-0.26-0.470.46-0.06-0.82-0.58-0.21-0.43-0.830.13-0.03-0.81-0.57-0.62-0.170.28-0.17-0.150.16-0.18
0.25-0.520.25-0.61-0.33-0.810.290.59-0.40.26-0.43-0.21-0.280.33-0.90.570.250.450.25-0.790.60.050.05-0.050.78
0.430.210.41-0.060.080.520.28-0.6-0.160.440.6-0.43-0.280.460.41-0.150.430.530.260.390.010.030.02-0.020.06
0.990.250.820.130.250.250.28-0.460.210.990.62-0.830.330.46-0.220.290.990.780.910.2-0.060.120.15-0.150.57
-0.160.37-0.170.490.210.71-0.25-0.540.15-0.160.430.13-0.90.41-0.22-0.32-0.16-0.3-0.170.7-0.5-0.28-0.280.29-0.65
0.26-0.260.04-0.26-0.08-0.430.190.29-0.210.27-0.17-0.030.57-0.150.29-0.320.270.40.26-0.390.34-0.34-0.30.30.69
1.00.330.80.230.350.330.25-0.510.311.00.66-0.810.250.430.99-0.160.270.710.920.29-0.120.150.18-0.180.52
0.7-0.040.57-0.26-0.17-0.020.27-0.25-0.170.730.38-0.570.450.530.78-0.30.40.710.62-0.120.18-0.13-0.120.120.64
0.920.330.620.280.340.29-0.13-0.370.330.920.49-0.620.250.260.91-0.170.260.920.620.34-0.180.170.2-0.20.52
0.290.730.140.770.550.94-0.33-0.710.630.270.6-0.17-0.790.390.20.7-0.390.29-0.120.34-0.690.040.07-0.07-0.42
-0.13-0.32-0.26-0.89-0.05-0.650.320.51-0.42-0.13-0.410.280.60.01-0.06-0.50.34-0.120.18-0.18-0.69-0.1-0.10.10.64
0.150.030.180.130.180.090.02-0.070.080.140.07-0.170.050.030.12-0.28-0.340.15-0.130.170.04-0.10.99-0.99-0.04
0.180.080.160.160.250.110.02-0.090.140.170.09-0.150.050.020.15-0.28-0.30.18-0.120.20.07-0.10.99-1.00.0
-0.18-0.08-0.17-0.15-0.25-0.1-0.020.08-0.14-0.17-0.090.16-0.05-0.02-0.150.290.3-0.180.12-0.2-0.070.1-0.99-1.0-0.01
0.52-0.090.19-0.510.12-0.460.230.29-0.130.51-0.12-0.180.780.060.57-0.650.690.520.640.52-0.420.64-0.040.0-0.01
Click cells to compare fundamentals

Anatara Lifesciences Account Relationship Matchups

Anatara Lifesciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.3M4.3M1.8M1.4M1.7M1.6M
Total Current Liabilities464.0K402.6K358.1K494.2K304.2K369.0K
Cash2.7M3.4M1.1M351.2K982.1K933.0K
Net Receivables630.3K772.6K508.5K1.0M671.1K518.6K
Total Liab487.0K496.7K403.4K494.8K306.8K433.2K
Common Stock17.0M19.8M19.9M21.4M23.2M14.6M
Other Current Assets23.7K37.1K22.0K10.9K17.4K16.6K
Other Current Liab430.2K192.9K184.8K415.3K56.1K53.3K
Total Stockholder Equity2.9M3.8M1.4M924.5K1.4M1.3M
Net Debt(2.7M)(3.4M)(1.1M)(351.2K)(982.1K)(1.0M)
Retained Earnings(14.7M)(16.6M)(19.0M)(20.8M)(22.1M)(21.0M)
Accounts Payable33.9K195.6K152.6K78.8K248.0K149.2K
Cash And Short Term Investments2.7M3.4M1.2M401.2K982.1K933.0K
Common Stock Shares Outstanding54.6M69.0M78.2M104.3M150.0M157.5M
Liabilities And Stockholders Equity3.3M4.3M1.8M1.4M1.7M1.6M
Other Stockholder Equity(2.3M)(3.2M)(924.8K)(576.8K)(519.2K)(545.1K)
Total Current Assets3.3M4.2M1.7M1.4M1.7M1.6M
Net Tangible Assets2.9M3.8M1.4M924.5K832.1K790.5K
Property Plant And Equipment Net7.2K85.0K66.9K3.3K794.0754.3
Non Current Assets Total7.2K85.0K66.9K3.3K794.0754.3
Non Currrent Assets Other(27.2K)(7.2K)(85.0K)(66.9K)(3.3K)0.0
Short Term Investments6.2M4.1M0.050K50.1K47.6K
Property Plant And Equipment Gross7.2K85.9K87.8K3.3K794.0754.3
Accumulated Other Comprehensive Income553.3K678.5K439.5K347.7K278.0K442.9K
Property Plant Equipment7.2K85.0K66.9K3.3K3.7K3.6K
Non Current Liabilities Total22.9K94.1K45.2K665.02.7K2.6K
Net Invested Capital2.9M3.8M1.4M924.5K1.4M1.3M
Net Working Capital2.9M3.8M1.3M921.9K1.4M1.3M
Other Liab22.9K28.3K81.0665.0598.5568.57
Capital Stock17.0M19.8M19.9M21.4M23.2M21.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Anatara Stock Analysis

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.